The Cardiovascular Disease (CVD) and Diabetes Screening Program offers a screening, including blood pressure, lipid panel and A1C tests. All participants receive a risk profile letter that outlines their results.

Phase 1: Cardiovascular Disease (CVD) and Diabetes Screening

The purpose of the CVD screening is to identify employees at varying levels of risk for CVD. CVD risk screenings are available for all KSC and CCAFS employees and will be announced in the KSC Daily News & NASA Community. Parameters measured include exercise frequency, blood pressure, weight, height, body mass index, total cholesterol (including HDL and LDL cholesterol) and triglycerides. The Diabetes Screening is offered through an A1C test for employees who select to have it. It is recommended participants complete questionnaires prior to the screening. Fasting results include no food or caloric beverages 12 hours prior, but fasting is not required and participants should consult their primary care provider, prior to fasting, if diabetic. The lipid panel (total cholesterol & triglycerides) and A1C are affected little, if at all, when not fasting vs. fasting.

CVD and Diabetes Screening Schedule 

OHF – Occupational Health Facility (M6-495, KSC Industrial Area)

Date	Place	Time
October 29, 2024	OHF	7:30 – 9:00 am
January 14, 2025	OHF	1:00 – 2:00 pm
April 29, 2025	OHF	7:30 – 9:00 am
July 15, 2025	OHF	1:00 – 2:00 pm

The 2-page CVD and Diabetes Screening Program, Form Number 28-1010 in NASA Electronic Forms (NEF), can be picked up at the OHF, KSC Fitness Center, or if you have access to NASA SharePoint, download HERE. Please complete the 2 pages on separate sheets, and bring them with you the day of your screening.

Phase 2: CVD Risk Follow Up

The purpose of this phase is to educate employees concerning their CVD risk. CVD education is provided through both the risk profile letter, and with additional resources for high risk employees, which is included with their letter.